Prostate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma (Q36149384)

12 August 2017

1 reference

title

Prostate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma (English)

1 reference

12 August 2017

1 reference

Eckart Gronau

1

1 reference

12 August 2017

Marcus Goppelt

series ordinal

2

1 reference

12 August 2017

Rolf Harzmann

series ordinal

3

1 reference

12 August 2017

Dorothea Weckermann

series ordinal

4

1 reference

12 August 2017

publication date

2 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

28

1 reference

12 August 2017

issue

6-7

1 reference

12 August 2017

page(s)

361-366

1 reference

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

12 August 2017

cites work

1 reference

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

21 January 2018

1 reference

Laparoscopic retropubic simple prostatectomy

21 January 2018

1 reference

A systematic overview of radiation therapy effects in prostate cancer

21 January 2018

1 reference

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

Prostate cancer: radical prostatectomy

21 January 2018

1 reference

Markers and meaning of primary treatment failure

21 January 2018

1 reference

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

21 January 2018

1 reference

The natural history of androgen independent prostate cancer

21 January 2018

1 reference

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy

21 January 2018

1 reference

Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation

21 January 2018

1 reference

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

21 January 2018

1 reference

Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer

21 January 2018

1 reference

Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatment

21 January 2018

1 reference

Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer

21 January 2018

1 reference

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

21 January 2018

1 reference

Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues

21 January 2018

1 reference

Hormonal therapy: historical perspective to future directions

21 January 2018

1 reference

Dual HER 1-2 targeting of hormone-refractory prostate cancer by ZD1839 and trastuzumab

21 January 2018

1 reference

Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000085661

1 reference

12 August 2017

1 reference